Eroglu A - Search Results

1

The role of Factor V Leiden in adult patients with venous thromboembolism: a meta-analysis of published studies from Turkey.

Eroglu A, Sertkaya D, Akar N. Eroglu A, et al. Clin Appl Thromb Hemost. 2012 Jan-Feb;18(1):40-4. doi: 10.1177/1076029611412369. Epub 2011 Jul 6. Clin Appl Thromb Hemost. 2012. PMID: 21733936 Free article.

2

PT G20210A, factors V G1691A and 1299 His-Arg mutations and tamoxifen-associated thromboembolism in patients with breast cancer.

Eroğlu A, Cam R, Yildiz Z, Akar N. Eroğlu A, et al. Thromb Res. 2003;111(4-5):317-9. doi: 10.1016/j.thromres.2003.09.011. Thromb Res. 2003. PMID: 14693181 Clinical Trial. No abstract available.

3

PT G20210A and factor V Leiden mutations and isolated limb perfusion-associated thrombosis in patients with soft tissue sarcoma.

Eroğlu A, Ulu A, Erekul S, Akgul H, Akar N. Eroğlu A, et al. Thromb Haemost. 2004 Apr;91(4):837-8. Thromb Haemost. 2004. PMID: 15045156 No abstract available.

4

Factor V Leiden and PT G20210A mutations in cancer patients with and without venous thrombosis.

Eroglu A, Kurtman C, Ulu A, Cam R, Akar N. Eroglu A, et al. J Thromb Haemost. 2005 Jun;3(6):1323-4. doi: 10.1111/j.1538-7836.2005.01346.x. J Thromb Haemost. 2005. PMID: 15946230 Free article. No abstract available.

5

23-bp endothelial protein C receptor (EPCR) gene insertion mutation in cancer patients with and without thrombosis.

Eroĝlu A, Ulu A, Kurtman C, Cam R, Akar N. Eroĝlu A, et al. Am J Hematol. 2006 Mar;81(3):220. doi: 10.1002/ajh.20519. Am J Hematol. 2006. PMID: 16493612 Free article. No abstract available.

6

Vascular endothelial growth factor 936 C/T polymorphism in cancer patients.

Eroglu A, Gulec S, Kurtman C, Cam R, Akar N. Eroglu A, et al. Ann Oncol. 2006 Sep;17(9):1467-8. doi: 10.1093/annonc/mdl075. Epub 2006 Apr 6. Ann Oncol. 2006. PMID: 16600977 Free article. No abstract available.

7

Vascular endothelial growth factor C936T polymorphism in cancer patients with thrombosis.

Eroglu A, Gulec S, Akar N. Eroglu A, et al. Am J Hematol. 2007 Feb;82(2):174. doi: 10.1002/ajh.20719. Am J Hematol. 2007. PMID: 16917915 Free article. No abstract available.

8

Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in cancer patients with and without thrombosis.

Eroglu A, Ulu A, Akar N. Eroglu A, et al. J Thromb Thrombolysis. 2006 Oct;22(2):111-2. doi: 10.1007/s11239-006-9054-z. J Thromb Thrombolysis. 2006. PMID: 17008976 No abstract available.

9

Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients.

Eroglu A, Ulu A, Cam R, Kurtman C, Akar N. Eroglu A, et al. J Thromb Thrombolysis. 2007 Feb;23(1):31-4. doi: 10.1007/s11239-006-9001-z. J Thromb Thrombolysis. 2007. PMID: 17106650

10

Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.

Eroglu A, Ulu A, Cam R, Akar N. Eroglu A, et al. J BUON. 2006 Oct-Dec;11(4):481-4. J BUON. 2006. PMID: 17309181

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

496 results

Search Page

Filters